Matritech Announces Listing of Common Stock on Nasdaq National Market
NEWTON, Mass., Aug. 5 /PRNewswire/ -- Matritech announced that effective tomorrow, Wednesday, August 6, Matritech's common stock will trade on the
Nasdaq National Market under the symbol ``NMPS''. Matritech's Common Stock is currently traded on the Nasdaq SmallCap Market and the Company was
notified by Nasdaq last week that Matritech's Common Stock had been approved for listing on the National Market. In connection with this approval, Matritech's
common stock will cease to trade on the Boston Stock Exchange.
Matritech, Inc., based in Newton, Mass., is using proprietary nuclear matrix protein (NMP) technology, discovered at the Massachusetts Institute of Technology
(MIT) and licensed exclusively to Matritech, to develop and commercialize innovative serum-, cell- and urine-based NMP diagnostics that enable physicians to
reliably detect and monitor the presence of bladder, colorectal, cervical, breast and prostate cancers.
SOURCE: Matritech, Inc. |
